(VIANEWS) – ServiceNow (NOW), United Bankshares (UBSI), Amphastar Pharmaceuticals (AMPH) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. ServiceNow (NOW)
21.5% sales growth and 7.45% return on equity
ServiceNow, Inc. provides enterprise cloud computing solutions that defines, structures, consolidates, manages, and automates services for enterprises worldwide. The company operates the Now platform for workflow automation, artificial intelligence, machine learning, robotic process automation, process mining, performance analytics, electronic service catalogs and portals, configuration management systems, data benchmarking, encryption, and collaboration and development tools. It also provides information technology (IT) service management applications; IT service management product suite for enterprise's employees, customers, and partners; strategic portfolio management product suite; IT operations management product that connects a customer's physical and cloud-based IT infrastructure; IT asset management; and security operations that connects with internal and third party. In addition, the company offers integrated risk management product to manage risk and resilience; environmental, social and governance management product; human resources, legal, and workplace service delivery products; safe workplace suite products; customer service management product; and field service management applications. Further, it provides App Engine product; Automation Engine enables application to extend workflows; platform privacy and security product; procurement operations management suite; and professional and customer support services. The company serves government, financial services, healthcare, telecommunications, manufacturing, IT services, technology, oil and gas, education, and consumer products through direct sales team and resale partners. It has a strategic partnership with Celonis to help customers identify and prioritize processes that are suitable for automation. The company was formerly known as Service-now.com and changed its name to ServiceNow, Inc. in May 2012. The company was founded in 2004 and is headquartered in Santa Clara, California.
Earnings Per Share
As for profitability, ServiceNow has a trailing twelve months EPS of $0.76.
PE Ratio
ServiceNow has a trailing twelve months price to earnings ratio of 568.82. Meaning, the purchaser of the share is investing $568.82 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.45%.
2. United Bankshares (UBSI)
7.4% sales growth and 8.22% return on equity
United Bankshares, Inc., a financial holding company, primarily provides commercial and retail banking products and services in the United States. It operates through two segments, Community Banking and Mortgage Banking. The company accepts checking, savings, and time and money market accounts; individual retirement accounts; and demand deposits, statement and special savings, and interest-bearing checking accounts. Its loan products include commercial loans and leases; construction and real estate loans; personal, credit card, commercial, and floor plan loans; and credit card and home equity loans. In addition, the company provides credit cards; safe deposit boxes, wire transfers, and other banking products and services; investment and security services; services to correspondent banks, including buying and selling federal funds; automated teller machine services; and internet and telephone banking services. Further, it offers community banking services, such as asset management, real property title insurance, financial planning, mortgage banking, and brokerage services. As of January 28, 2021, the company operated 230 offices in West Virginia, Virginia, Ohio, Pennsylvania, Maryland, North Carolina, South Carolina, Georgia, and Washington, D.C. United Bankshares, Inc. was incorporated in 1982 and is headquartered in Charleston, West Virginia.
Earnings Per Share
As for profitability, United Bankshares has a trailing twelve months EPS of $2.84.
PE Ratio
United Bankshares has a trailing twelve months price to earnings ratio of 12.6. Meaning, the purchaser of the share is investing $12.6 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.22%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 25% and 4.2%, respectively.
3. Amphastar Pharmaceuticals (AMPH)
7.1% sales growth and 16.51% return on equity
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Earnings Per Share
As for profitability, Amphastar Pharmaceuticals has a trailing twelve months EPS of $0.03.
PE Ratio
Amphastar Pharmaceuticals has a trailing twelve months price to earnings ratio of 1213.67. Meaning, the purchaser of the share is investing $1213.67 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.51%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.1%, now sitting on 484.85M for the twelve trailing months.
Volume
Today’s last reported volume for Amphastar Pharmaceuticals is 74840 which is 69.59% below its average volume of 246159.
Yearly Top and Bottom Value
Amphastar Pharmaceuticals’s stock is valued at $36.41 at 06:22 EST, way under its 52-week high of $44.46 and way above its 52-week low of $26.76.
Previous days news about Amphastar Pharmaceuticals(AMPH)
- According to Zacks on Monday, 27 March, "The bottom line of Amphastar Pharmaceuticals outpaced estimates in all the last four quarters, the average surprise being 35%."
4. Stag Industrial (STAG)
7% sales growth and 7.36% return on equity
STAG Industrial, Inc. (NYSE: STAG) is a real estate investment trust focused on the acquisition and operation of single-tenant, industrial properties throughout the United States. By targeting this type of property, STAG has developed an investment strategy that helps investors find a powerful balance of income plus growth.
Earnings Per Share
As for profitability, Stag Industrial has a trailing twelve months EPS of $1.32.
PE Ratio
Stag Industrial has a trailing twelve months price to earnings ratio of 23.77. Meaning, the purchaser of the share is investing $23.77 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.36%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Feb 26, 2023, the estimated forward annual dividend rate is 1.47 and the estimated forward annual dividend yield is 4.07%.
Yearly Top and Bottom Value
Stag Industrial’s stock is valued at $31.37 at 06:22 EST, way under its 52-week high of $42.49 and way above its 52-week low of $26.56.
Sales Growth
Stag Industrial’s sales growth is 12.1% for the present quarter and 7% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 17%, now sitting on 634.64M for the twelve trailing months.
